US News

Snooki’s fat-loss pills are a big fat ‘lie’

Weight-loss claims about miracle diet pills hawked by former “Jersey Shore” star Nicole “Snooki” Polizzi are a big fat lie, according to a Brooklyn federal lawsuit filed Tuesday.

The pint-sized MTV celebrity and new mom credits the Zantrex-3 “dietary supplement” in celebrity magazines and on social media with helping her cure her chronic tubbiness.

“Zantrex-3 Fat Burner helps me see results and keeps me motivated,” she once told OK! magazine.

“Wanna look good like me? GTL & my fav Zantrex fat burner from Walgreens, it’s on sale!’ she tweeted in 2011 — before admitting she was being paid to endorse the product.

The jiggly Jerseyite even transformed herself from a chicken parm-chewing chubster to a slimmed-down fitness authority, equally at ease in a bikini or on “Dancing With the Stars.”

But Valley Stream, LI, resident Ashley Brady says the pills will only lighten wallets, according to her class-action suit.

Brady tried the pills but saw no benefits — despite claims that the product would a provide “546% more weight loss than America’s #1 selling Ephedra diet pill . . . in a little over 6 weeks of use . . . without exercise” — the suit claims.

“In fact, Zantrex’s main ingredient is a dangerously large dose of caffeine, which the Food and Drug Administration has determined is not safe or effective for weight control or appetite suppression,” the suit alleges.

The suit also names Zantrex manufacturers Basic Research and Zoller Laboratories.

“Defendants have marketed Zantrex through a multimedia advertising campaign featuring reality TV star Nicole Polizzi, a k a Snooki, whose image adorns nearly every advertisement for Zantrex,” the suit states.

“Snooki holds herself out as an expert in fitness,” the complaint states.

“In this regard, she has amassed many fans and followers who specifically follow and listen to her advice on weight loss and fitness.”

After Snooki was served with the suit, Zoller filed a defamation countersuit against Brady’s lawyers, Manhattan firm Bursor & Fisher.

Neither Brady nor a rep for Zantrex returned a call for comment.